NOV (NYSE: NOV) has recently received a number of price target changes and ratings updates:
- 11/4/2024 – NOV had its price target lowered by analysts at Wells Fargo & Company from $16.00 to $15.00. They now have an “underweight” rating on the stock.
- 10/29/2024 – NOV had its price target lowered by analysts at Barclays PLC from $17.00 to $16.00. They now have an “underweight” rating on the stock.
- 10/28/2024 – NOV had its price target lowered by analysts at Susquehanna from $22.00 to $21.00. They now have a “positive” rating on the stock.
- 10/28/2024 – NOV had its price target lowered by analysts at Stifel Nicolaus from $25.00 to $24.00. They now have a “buy” rating on the stock.
- 10/28/2024 – NOV had its price target lowered by analysts at TD Cowen from $28.00 to $22.00. They now have a “buy” rating on the stock.
- 10/16/2024 – NOV had its price target lowered by analysts at Barclays PLC from $20.00 to $17.00. They now have an “underweight” rating on the stock.
- 10/14/2024 – NOV had its price target lowered by analysts at Bank of America Co. from $22.00 to $20.00. They now have a “buy” rating on the stock.
- 10/11/2024 – NOV had its price target lowered by analysts at Susquehanna from $26.00 to $22.00. They now have a “positive” rating on the stock.
- 10/11/2024 – NOV had its price target lowered by analysts at Stifel Nicolaus from $26.00 to $25.00. They now have a “buy” rating on the stock.
- 10/10/2024 – NOV had its price target lowered by analysts at BMO Capital Markets from $22.00 to $20.00. They now have a “market perform” rating on the stock.
- 10/3/2024 – NOV had its price target lowered by analysts at JPMorgan Chase & Co. from $23.00 to $22.00. They now have an “overweight” rating on the stock.
- 10/3/2024 – NOV had its price target lowered by analysts at Citigroup Inc. from $24.00 to $21.00. They now have a “buy” rating on the stock.
- 9/25/2024 – NOV was downgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating. They now have a $16.00 price target on the stock, down previously from $20.00.
- 9/16/2024 – NOV had its price target lowered by analysts at Morgan Stanley from $25.00 to $23.00. They now have an “overweight” rating on the stock.
NOV Stock Performance
Shares of NOV stock opened at $15.39 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.57 and a quick ratio of 1.65. The firm has a market cap of $5.99 billion, a P/E ratio of 5.68, a P/E/G ratio of 0.89 and a beta of 1.66. The firm has a 50 day simple moving average of $16.26 and a 200 day simple moving average of $17.68. NOV Inc. has a fifty-two week low of $14.98 and a fifty-two week high of $21.23.
NOV Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, September 27th. Stockholders of record on Friday, September 13th were given a dividend of $0.075 per share. The ex-dividend date of this dividend was Friday, September 13th. This represents a $0.30 dividend on an annualized basis and a dividend yield of 1.95%. NOV’s dividend payout ratio is 11.07%.
Hedge Funds Weigh In On NOV
NOV Inc designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular inspection and coating services, instrumentation, downhole tools, and drill bits.
See Also
- Five stocks we like better than NOV
- Most Volatile Stocks, What Investors Need to Know
- Intel: Is Now the Time to Be Brave?Â
- What is a Bond Market Holiday? How to Invest and Trade
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for NOV Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NOV Inc and related companies with MarketBeat.com's FREE daily email newsletter.